로딩 중…
지수 로딩 중…
Tango Therapeutics Inc.
TNGX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$27.87-13.69%
2026-06-18
Price Chart
Tango Therapeutics Inc.+480.63%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $4.03B |
| Revenue | $57M |
| Net Income | $-107M |
| Total Assets | $436M |
| Net Assets | $392M |
| Value | |
| P/B | 10.30x |
| P/S | 70.74x |
| FCF Yield | -3.54% |
| Profitability | |
| ROE | -27.39% |
| ROA | -24.61% |
| Op. Margin | -206.22% |
| Revenue Growth | -100.00% |
| Financial Health | |
| Debt Ratio | 11.31% |
| Total Debt | $33M |
| FCF | $-143M |
| Cash | $158M |
| Current Ratio | 27.38x |
| Performance | |
| 1Y Return | 480.63% |
| 1M Return | 37.29% |
| From 52W High | -18.96% |
| 1Y MDD | -29.24% |
| Trading | |
| Volume | 11,811,891 shares |
| Trading Value | $344M |